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media on transdifferentiation of human DPSCs (hDPSCs) into neuron-like cells.
Methods: Isolation, cultivation, and identification of hDPSCs were performed with morpholog-
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XTT [(2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide)] assay. Me-
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pared. The efficacy of neural induction was evaluated by detecting the expression of neuron
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expressed a higher density of neuron cell markers than those before induction.have no conflicts of interest relevant to this article.
stitute of Clinical Dentistry, School of Dentistry, National Taiwan University, Number 1, Chang-Te
com (C.-P. Lin).
4.09.003
Taiwan LLC & Formosan Medical Association. All rights reserved.
Dental pulp stem cells into neuron-like cells 957Conclusion: These findings suggest that in response to the neuronal inductive stimuli, a greater
proportion of DPSCs stop proliferation and acquire a phenotype resembling mature neurons.
Such neural crest-derived adult DPSCs may provide an alternative stem cell source for
therapy-based treatments of neuronal disorders and injury.
Copyright ª 2014, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Nerve degeneration or damage may cause severe complica-
tions leading to severe disability in patients. The use of stem
cell therapy for nerve regeneration may be an important
strategy for treatment. Mesenchymal stem cells (MSCs) or
bonemarrow stem cells (BMSCs) may be used as the source of
stem cells for nerve regeneration treatment. Several
studies have demonstrated the ability of MSCs to
transdifferentiate into functional cells of the nervous sys-
tem.1e6 MSCs cultured in neural stem cell (NSC) culture
conditions can further differentiate into astrocytes, neurons,
and oligodendrocytes.7e9 However, the transdifferentiating
efficacy of MSCs and BMSCs is low and unpredictable.
Recently, dental pulp cells (DPCs) and dental pulp stem
cells (DPSCs) have been proposed as a promising source of
stem cells in nerve regeneration due to their close embryonic
origin and ease of harvest.10,11 DPSCs are a source of pro-
genitor/stem cells that can proliferate and differentiate into
multiple cell lineages in vitro.10,11 Interestingly, DPSCs orig-
inate from the cranial neural crest and have neural
characteristics.12 The dental pulp tissue is termed ‘‘ecto-
mesenchyme’’, because it derives from ectodermal cells
growing on the periphery of the neural tube during embryonic
development, migrating into the oral region, and trans-
differentiating into a mesenchymal phenotype. MSCs are
immune-privileged and their propagation is not challenged by
ethical concerns.13 Therefore, DPSCs may represent a
promising source in cell therapy for neurological disorders.
DPCs can significantly promote survival of embryonic
tyrosine hydroxylase (TH)-positive neurons in culture,
because DPCs can release some neurotropic factors.14 In
animal studies, grafting of dental pulp tissue into hemi-
sected spinal cord increases the number of surviving motor
neurons. Neurotropic factors secreted from the implanted
dental pulp tissue are considered to be the main contrib-
utor towards the rescuing effect on motor neurons.15 Even
under non-neuronal inductive conditions, human adult DPCs
and DPSCs can express neural progenitor marker nestin and
glial marker glial fibrillary acidic protein (GFAP) at both the
gene and protein levels.16 DPSCs can differentiate into a
variety of cell lineages, including adipocytes, odonto-
blasts,10 neural cells,17 and glial cells.11,18 Following ex vivo
expansion, such multipotential DPSCs still retain their
neural crest properties.19e21 Under neural inductive con-
ditions, DPSCs can express the postmitotic neuron-specific
marker neuronal nuclei (NeuN), which indicates their po-
tential in neural differentiation.11
Although DPSCs in media supplemented with differenti-
ation factors can differentiate into neuron-like cells, their
differentiations are incomplete.22 Previous studies
compared murine DPCs with murine retinal progenitor cellsto evaluate their potential for differentiation into neuron-
like cells. The differentiation of the murine DPCs into glial-
and neuron-like cells was incomplete. After differentiation,
37% of murine retinal progenitor cells, but only 5% of murine
DPCs, expressed the astroglia cell-marker GFAP.23 We hy-
pothesized that DPSCs exposed to the appropriate environ-
mental conditions would differentiate into functionally
active neurons. Moreover, neural crest-derived adult DPSCs
might provide an alternative stem cell source for therapy-
based treatments for neuronal disorders and injury.
This study examined the neuronal differentiation poten-
tial of adult human DPSCs (hDPSCs) in vitro. The aim of this
study was to evaluate the neuronal differentiation potential
of hDPSCs into neuron-like cells in both dopaminergic and
motor neuronal inductive media containing growth factors
such as brain-derived neurotrophic factor (BDNF), glial cell
line-derived neurotrophic factor (GDNF), basic fibroblast
growth factor (bFGF), and retinoic acid.24e27 The expression
of neuron cell-specific cell markers in hDPSCs cultured in
neuronal induction media was assessed by immunocyto-
chemistry and quantitative real-time reverse transcription
polymerase chain reaction (RT-PCR).Methods
Materials
Dulbecco’s modified Eagle’s medium (DMEM) and F12 media
(DMEM/F12), fetal calf serum (FCS), N2 supplements,
penicillin, and streptomycin were obtained from Invitrogen
(Carlsbad, CA, USA); insulin-like growth factor (IGF)-I and
transforming growth factor (TGF)-bIII from Prospec Protein
Specialists (Rehovot, Israel); and retinoic acid and cyclic
adenosine monophosphate (cAMP) from Sigma-Aldrich Corp.
(St. Louis, MO, USA). Other cytokines were purchased from
PeproTech Systems (Rocky Hill, NJ, USA). Goat polyclonal
anti-choline acetyltransferase antibody (anti-ChAT), rabbit
polyclonal anti-GFAP, rabbit polyclonal anti-dopa decar-
boxylase (anti-DDC), mouse monoclonal anti-tyrosine hy-
droxylase (anti-TH), mouse monoclonal anti-neuronal
nuclei (anti-NeuN), mouse monoclonal anti-bIII-tubulin
(anti-bIII-tub), and mouse monoclonal anti-oligodendrocyte
(anti-O1) were purchased from Chemicon-Millipore (Bill-
erica, MA, USA); poly-L-lysine (PLL) was obtained from
ScienCell Research Laboratories (Carlsbad, CA, USA).
GAPDH was purchased from Mission Biotech Co. (Taipei,
Taiwan), collagenase type I, dispase, L-glutamine, nones-
sential amino acids were purchased from Invitrogen
(Carlsbad, CA, USA). Sonic hedgehog, FGF-8b were pur-
chased from PeproTech Systems (Rocky Hill, NJ, USA).
Ascorbic acid, heparin, paraformaldehyde, NaCl, Tris-HCl,
958 C.-C. Chang et al.TBS, 0.1% Triton-X100, oil red, alizarin red were purchased
from Sigma-Aldrich Corp.(St. Louis, MO, USA) Agarose gel
was purchased from Sangon Biotechnology Co. (Shanghai,
China).
Isolation and cultivation of hDPSCs
hDPSC isolation and flow cytometry analyses were carried
out as described previously.10 Teeth were cleaned and
cracked open using a vice to reveal the pulp chamber.
The pulp tissue was gently separated from the crown and
the root, and then digested in a solution containing
3 mg/mL collagenase type I and 4 mg/mL dispase for
1 hour at 37C. Single-cell suspensions were obtained
by passing the cells through a 70 mm Cell Filter strainer.
DPSCs were grown in DMEM supplemented with 15% FCS,
2 mM L-glutamine, 100 mg/mL streptomycin, and
100 U/mL penicillin. The growth medium was replaced
twice a week, and cells were maintained at 37C in a
humidified 5% CO2 incubator.
Medium preparation for the induction of spinal
motor neuronal differentiation
The induction of spinal motor neuronal differentiation was
carried out as previously described28 with some modifica-
tions. DPSCs were used for experiments at passage 5. Cell
culture media were based on neuronal induction media
500 mL comprising DMEM/F12 489 mL containing N2 5 mL,
nonessential amino acids 5 mL, and heparin 1 mL (1 mg/mL)
supplements. On Day 0 of differentiation, the medium was
replaced with fresh neuronal induction medium supple-
mented with all-trans retinoic acid at a final concentration
of 0.1 mM. On Day 4, the cells were cultured in neuronal
induction medium containing sonic hedgehog (SHH)
(100 ng/mL) and retinoic acid (0.1 mM). On Day 6 of dif-
ferentiation, the cells were treated with neuronal induc-
tion medium supplemented with retinoic acid (0.1 mM), SHH
(100 ng/mL), cAMP (1 mM), and ascorbic acid (200 ng/mL).
On Day 9, the attached cells were treated with neuronal
induction medium supplemented with BDNF, GDNF, IGF-1
(10 ng/mL, respectively), cAMP (1 mM), and ascorbic acid
(200 ng/mL). The cells could be maintained in the same
medium for 9e15 days.
Medium preparation for the induction of
dopaminergic neuronal differentiation
The induction of dopaminergic neuronal differentiation was
carried out as previously described29 with some modifica-
tions. DPSCs at passage 5 were used for the experiments.
Cell culture media were based on N2 media 500 mL
comprising DMEM/F12 495 mL and N2-A 5 mL supplements.
On Day 0 of differentiation, the medium was replaced with
fresh N2 media supplemented with noggin at the final
concentration of 300 ng/mL. On Day 4, the cells were
cultured in BASF media containing N2 medium, BDNF 50 mg/
mL, ascorbic acid 200 mM, SHH 50 mg/mL, and FGF-8b
50 mg/mL. On Day 9 of differentiation, the cells were
treated with BASF medium without bFGF for another 3 days
in culture. On Day 12, the attached cells were treated withBCT-GA medium containing N2 medium, BDNF 50 mg/mL,
ascorbic acid 200 mM, GDNF 10 ng/mL, TGF-bIII 2 mg/mL,
and cAMP 200 mM. The cells could be maintained in the
same medium for 12e15 days.
XTT assay
The cell viability was determined 15 days after seeding
the cells using an XTT [(2,3-bis-(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide)] Cell Prolif-
eration Kit (Biological Industries, Kibbutz Beit HaEmek,
Israel). The procedure is based on the activity of mito-
chondrial dehydrogenase, which is inactivated shortly after
cell death. XTT is metabolized to form a soluble formazan
dye that can be colorimetrically determined at 490 nm
using a spectrophotometer (Thermo Varioskan Flash;
Thermo, NH, USA). After incubation for 0 days, 4 days,
9 days, 12 days, and 15 days, 50 mL of XTT reaction solution
was added to each well for another 3 hours of incubation.
Six parallel replicates were prepared. Controls underwent
the same treatment.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde and washed in
Tris-buffered saline (TBS; 0.15 M NaCl, 0.1 M TriseHCl, pH
7.5), then blocked with a solution composed of TBS, 0.1%
Triton-X100 (only for intracellular antigens), and 1% bovine
serum albumin (BSA). The same solution was used during
the incubations with antibodies. Primary antibodies were
applied overnight at 4C. Fluorochrome-conjugated spe-
cies-specific secondary antibodies were used for immuno-
detection. The proteins of nestin and bIII-tubulin (bIII-tub)
are found almost exclusively in neurons. GFAP is an
intermediate-filament protein that is highly specific for
cells of astroglial lineage. O1 is an antigen characteristic of
oligodendrocyte neuronal-associated markers expressed by
DPSCs cultured in different neuronal inductive conditions
and determined by immunocytochemical analysis. The
following antibodies and final dilutions were used. Primary
antibodies were anti-NeuN, -GFAP, -nestin, and -b-III-tub.
For negative controls, the primary antibodies were
omitted. PBS instead of the primary antibodies was used for
negative controls. Secondary antibodies were FITC-
conjugated goat anti-mouse immunoglobulin G (IgG),
rhodamine-conjugated goat anti-mouse IgG, FITC-
conjugated goat anti-rabbit IgG, rhodamine-conjugated
goat anti-rabbit IgG, FITC-conjugated rat anti-goat IgG,
and R-Phycoerythrin (RPE)-conjugated rabbit anti-goat IgG
(Millipore, Billerica, MA, USA). Nuclei were counterstained
with 4,6-diamidino-2-phenylindole (DAPI; Sigma) at
0.25 mg/mL. All the samples were examined under a fluo-
rescence microscope (Leica Optical, Wetzlar, Germany). To
quantify the number of cells positive for dopaminergic or
neuronal markers and the number of cells coexpressing
both types of markers, captures of immunostained cultures
derived from two different donors were obtained. Cell
counts for single- or double-labeled specimens were per-
formed on three nonoverlapping randomly selected fields in
cultures. The results were expressed as mean  standard
deviation (SD).
Table 1 Primers for PCR.
Target cDNA Oligonucleotide primer sequences Length (bp) NCBI no./refs
Adipogenic marker primer
PPAR-2 Sense 50-GCTGTGCAGGAGATCACAGA-30
Antisense 50-GGGCTCCATAAAGTCACCAA-30
220 NM-005037
LPL Sense 50-GTCCGTGGCTACCTGTCA-30
Antisense 50-TGTCCCACCAGTTTGGTGTA-30
200 NM-000237
Osteogenic marker primer
ALP Sense 50-ATGCAGGCTGCAATACGCCA-30
Antisense 50-ATCTTTGGTCTGGCCCCCAT-30
250 NM-000478.4
BSP Sense 50-TTCCTCCTCCTCTTCTGAACTG-30
Antisense 50-ATGGCCTGTGCTTTCTAAT-30
200 NM-004967.3
Stem cell marker primer
Oct-4 Sense 50-CGACCATCTGCCGCTTTGAG-30
Antisense 50-CCCCCTGTCCCCCATTCCTA-30
577 HQ-122891.1
Nanog Sense 50-CAGAAGGCCTCAGCACCT-30
Antisense 50-CTGTTCCAGGCCTGATTGTT-30
216 NM-024865.3
Neuron stem cell marker primer
Nestin Sense 50-GGAGTCCTGGATTTCCTTCC-30
Antisense 50-GCCCTGACCACTCCAGTTT-30
220 NM-006617.1
bIII-tub Sense 50-CTCAGGGGCCTTTGGACATC-30
Antisense 50-CAGGCAGTCGCAGTTTTCAC-30
150 AF-427491.3
GAPDH Sense 50-AGCCGCATCTTCTTTTGCGT-30
Antisense 50-TCATATTTGGCAGGTTTTTCT-30
760 NM-002046.3
ALP Z alkaline phosphatase; bIII-tub Z bIII-tubulin; bp Z base pairs; BSP Z bone sialoprotein; cDNA Z complementary DNA;
GAPDH Z glyceraldehyde 3-phosphate dehydrogenase; LPL Z lipoprotein lipase; NCBI Z National Center for Biotechnology Informa-
tion; PCR Z polymerase chain reaction; PPAR-2 Z peroxisome proliferator-activated receptor.
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Total RNA was extracted from the cells with RNeasy Mini kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
protocol. The gene-specific primers listed in this experi-
ment are described in Table 1. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was used as an internal control.
The PCR products were resolved by 1.7% agarose gel and
confirmed by DNA sequencing (Sangon Biotechnology Co.,
Shanghai, China).
Results
Culture, identification, and characterization of
DPSCs
After a single-step enzymatic treatment, viable cells with
elongated shapes were detected 1 day after the onset of
culturing. These cells formed colonies upon further cul-
tures. Cells from a single colony were isolated and sub-
cultured mechanically (1st passage). Subcultured cells
gradually became flattened and acquired a fibroblast-like
morphology (Fig. 1). In this study, the presented results
were from one single colony. Moreover, hDPSCs were also
tested to determine their expression of stem cell-specific
transcription factors. The expression of adipogenic peroxi-
some proliferator-activated receptor 2 (PPAR2) and lipo-
protein lipase (LPL), osteogenic alkaline phosphatase (ALP)
and bone sailoprotein (BSP), and stem cell (Oct-4 and
Nanog) markers were also detected by RT-PCR. These re-
sults confirmed that DPSCs are capable of differentiationinto at least two different cell types, such as adipogenic
and osteogenic cells (Fig. 2).
The expression profiles of a total of nine cell surface
antigens were shown in hDPSCs (Fig. 3), and these were also
compared with published profiles of hDPSCs.30 CD44, CD73,
CD90, CD105, and CD166, which are common hDPSC
markers, were expressed in our hDPSCs. However, CD14,
CD34, and CD45, the markers specific for hematopoietic
cells, were not expressed in our hDPSCs. These results
indicate that our hDPSCs are comparable to the expression
profiles of hDPSCs.30Morphological change of DPSCs following neuronal
induction
In order to assess the efficacy of different media formulations
on dopaminergic and spinal motor neuronal differentiation of
hDPSCs, we used two different neuronalmedia to promote the
neuronal differentiation of embryonic stem cells as previously
described28,29 with some modifications. Morphological
changes in the spindle shape of DPSCs appeared by Day 5 of
differentiation and peaked by Day 15when themajority of the
cells assumed amultipolar appearance with cellular processes
extending from cell bodies (Fig. 4). However, some fibroblast-
likecellswith spread-outmorphologywerestill observed in the
population. A small fractionofflat, roundoligodendrocyte-like
cells was also observed; the proportionwas bigger in the group
platedwithhighcell density (datanot shown).This study found
that DPSCs fulfilled these criteria, because DPSCs cultured in
expansionmedium (DMEMþ 10% FCS) expressed constitutively
neuronal markers bIII-tub and nestin (Fig. 4).
Figure 1 Morphological changes in dental pulp stem cells (DPSCs) in cultures at early time points. Cell morphology of one
representative DPSC culture at (A) Day 1, (B) Day 4, (C) Day 7, and (D) Day 14. Cultured cells gradually became flattened and
acquired a fibroblast-like morphology. (AeD, magnification 20, after plating).
960 C.-C. Chang et al.Proliferation potential of DPSCs
After 9 days of induction, DPSCs exposed to either dopa-
minergic or motor neuronal inductive media acquired
neuron-like morphology. Assessment of the cellFigure 2 Characterization of human dental pulp stem cells (hD
culturing under adipogenic conditions for 15 days, hDPSCs formed
osteogenic medium for 15 days, hDPSCs formed mineralized nodule
and LPL), osteogenic (ALP and BSP), and stem cell (Oct-4 and Nanproliferation status of DPSCs over the same period showed
that there was a significant 2.6- and 2-fold increase in the
proliferation rate of DPSCs cultured in dopaminergic
neuronal inductive media (p < 0.002; Student t test) and
spinal motor neuronal inductive media (p < 0.004) for 15PSCs). hDPSCs are spindle- and fibroblast-like cells. (A) After
lipid droplets when stained with oil red. (B) When culturing in
s by alizarin red staining. (C) Expression of adipogenic (PPAR2
og) markers.
Figure 3 Characterization of the human dental pulp stem cell (hDPSC) immunophenotype in vitro.
Dental pulp stem cells into neuron-like cells 961days, respectively, compared with those in control cul-
tures, as demonstrated by the XTT assay (Fig. 5).Quantity analysis of neuronal induction of DPSCs in
dopaminergic and motor neuronal inductive media
We assessed two different neuronal media conditions that
were described previously to promote neuronal differenti-
ation only in embryonic stem cells.28,29 The proteinFigure 4 Dental pulp stem cells (DPSCs) cultured in neural ind
neurogenic [nestin and bIII-tubulin (bIII-tub)] markers that were d
(RT-PCR).expression patterns of bIII-tub, GFAP, and O1 neuronal-
associated markers expressed by DPSCs cultured in
different neuronal inductive media were determined by
immunocytochemical analyses (Fig. 6). The data demon-
strated a progressive increase in neuron (bIII-tub), astro-
glial cell (GFAP), and oligodendrocyte (O1) neuronal
markers after induction. The proportions of bIII-tub-, GFAP-
, and O1-positive cells were significantly higher (dopami-
nergic neuronal media: p < 0.05, p < 0.0005, and p < 0.05,
respectively; spinal motor neuronal media: p < 0.0005,uctive media expressed (A,B) neuron-like morphology and (C)
etermined by reverse transcription polymerase chain reaction
Figure 5 The proliferation potential of dental pulp stem
cells (DPSCs) following the neuronal differentiation assay is
represented as absorbance readings after an XTT [(2,3-bis-(2-
methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide)] assay of cells cultured in the corresponding
media. When DPSCs were cultured in dopaminergic or motor
neuronal inductive media for 15 days, there was a 2.6- or 2-fold
decrease in proliferation potential, respectively.
Figure 7 The number of dental pulp stem cells (DPSCs)
positively stained for the respective neuronal-specific anti-
bodies represented as a percentage of field of view. An in-
crease in bIII-tubulin (bIII-tub), glial fibrillary acidic protein
(GFAP), and O1 (red) staining was found in DPSCs cultured in
neuronal inductive conditions when compared with the con-
trol. Quantitative analyses of bIII-tub, GFAP, or O1 expression.
From 50 to 100 cells per group were analyzed in randomly
chosen fields. Data are mean  standard deviation (SD) of
triplicate cultures. *p < 0.05, **p < 0.005, and ***p < 0.0005;
Student t test.
962 C.-C. Chang et al.p < 0.005, and p < 0.005, respectively; Student t test) in
DPSCs cultured in both neuronal inductive media than in
DPSCs cultured in control media (Fig. 7). Collectively, these
data suggest that in response to neuronal inductive stimuli,
a greater proportion of DPSCs stopped proliferation but
acquired a phenotype resembling mature neurons.
After culturing the cells in the induction media for
15 days, immunofluorescence staining identified cellFigure 6 (AeC) The induction of dopaminergic neural different
staining of cultured DPSCs may express a variety of neuronal mark
(GFAP), and O1 (red) when cultured in dopaminergic neurogenic m
differentiation of DPSCs. Immunocytochemical staining of cultured
tub, GFAP, and oligodendrocyte (O1; green) when cultured in spina
cell nucleus. Scale bars Z 400 mm.populations expressing the neuronal protein bIII-tub.
Expression of the dopaminergic-like cell marker TH or
cholinergic motor neuron marker ChAT was also detected in
these cells. Double immunostaining showed that some cells
expressed bIII-tub and TH or ChAT. The percentages of theiation of dental pulp stem cells (DPSCs). Immunocytochemical
ers including bIII-tubulin (bIII-tub), glial fibrillary acidic protein
edia for 15 days. (DeF) The induction of spinal motor neural
DPSCs may express a variety of neuronal markers including bIII-
l motor neural media for 15 days. The blue fluorescence is the
Figure 8 Human dental pulp stem cell (hDPSC)-derived dopaminergic cells expressing the neuronal markers bIII-tubulin (bZ-tub)
and the dopamine neuron marker tyrosine hydroxylase (TH) 15 days after induced differentiation [the cell nuclei were counter-
stained with 4,6-diamidino-2-phenylindole (DAPI) in AeD]. hDPSC-derived spinal motor neural cells expressing the neuronal
markers bIII-tub and cholinergic neuron marker choline acetyltransferase (ChAT) 15 days after induced differentiation (the cell
nuclei were counterstained with DAPI in EeF). Scale bars Z 200 mm. The percentages of bIII-tub- and TH-positive cells in hDPSC-
derived dopaminergic cells and the percentages of bIII-tub- and ChAT-positive cells in hDPSC-derived spinal motor neuron cells
after induction were significantly higher than those before induction. Data are mean  standard deviation (SD) of triplicate cul-
tures. *p < 0.005 and **p < 0.0005; Student t test.
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964 C.-C. Chang et al.positive cells for bIII-tub and TH or ChAT are summarized in
Fig. 8. The data revealed progressive enhancement in bIII-
tub/TH (8.3  2.58% vs. 27.3  6.97%, p < 0.005) and bIII-
tub/ChAT (10.2  2.14% vs. 52.8  4.26%, p < 0.005). When
DPSCs were cultured in neuronal inductive media, the
protein level of the neuronal markers bIII-tub/TH or bIII-
tub/ChAT appeared to be unregulated. Collectively, these
results suggest that in response to the neuronal inductive
stimuli, DPSCs acquired a phenotype resembling neuron-
like cells.Discussion
Transplanted human MSC (hMSC) may alter the tissue
microenvironment in a way that promotes survival of
endogenous cells, including injured neurons, immature ol-
igodendrocytes, and oligodendrocyte progenitor cells.31
Thus, hMSCs cultured with neuronal inductive media may
transdifferentiate into neuron-like cells for nerve
regeneration.
Dopaminergic neuronal inductive media and motor
neuronal inductive media have been completely investi-
gated in hMSCs or BMSCs. Although the direct effect of
BMSC transplantation may be for cells to differentiate into
neuron-like cells, endothelial cells, and astrocytes,32 these
cells still have limited survival and differentiation.33 To
date, as we can see from searching the literature, there has
been no study on the effect of dopaminergic and motor
neuronal inductive media on DPSCs. Because DPSCs origi-
nate from the cranial neural crest and have neural char-
acteristics,12 we suggest culturing DPSCs in dopaminergic
and motor neuronal inductive media in order to obtain
neuron-like cells for therapeutic use. Investigations on the
expression of neuron-specific cell markers in DPSCs by
immunocytochemistry and quantitative RT-PCR revealed
that such inductive media may generate more completely-
developed neuron-like cells from hDPSCs.
This study showed that our DPSCs were also capable of
differentiation into adipocytes and osteogenic cells. Our
results are similar to the previous findings that DPSCs are
capable of differentiating into at least two different cell
types, which are normally derived from different embry-
onic germ layers.10
In the present study, differentiated cells began to divide
slowly after 24 hours of culture and continued to prolifer-
ate until the end of the differentiation period, suggesting
that the cells underwent differentiation immediately after
neuronal differentiation had been induced. Although the
number of cells increased upon the induction of differen-
tiation, the cells subsequently showed a reduction in
growth rate and focused on the differentiation process. In
this study, there was a decrease in DPSCs cultured in
dopaminergic or motor neuronal inductive media, respec-
tively, as revealed by the XTT assay.
We suggest that DPSCs changed gradually and differen-
tiated into neuron-like cells after 7 days when cultured in
serum-free medium, because changes that occurred in cell
microenvironments such as removal of serum and addition
of certain growth or differentiation factors were found to
be able to induce transdifferentiation of DPSCs in vitro.34,35
This study also found that DPSCs may transdifferentiateinto neuron-like cells when serum is absent during
culturing.
The proportions of bIII-tub, GFAP, and oligodendrocyte
(O1)-positive cells were significantly higher in DPSCs
cultured in both inductive media than in DPSCs cultured in
the control media. The high expression of both nestin and
bIII-tub in DPSCs cultured in both inductive media indicates
that DPSCs can differentiate into neuron-like cells in both
inductive media. Nestin is known to be expressed within
fibrous dental pulp tissue. However, its expression
continued to be detected by the majority of DPSCs
following neuronal induction; that is, expression of nestin
was increased when cells differentiated into neurons.22 bIII-
tub is expressed only after neuronal differentiation and is
therefore utilized as a marker of mature neuron cells during
the final stages of growth.36,37 Furthermore, hDPSC-derived
dopaminergic and spinal motor neuron-like cells expressed
significantly higher neuronal markers than before induc-
tion. These findings suggest that in response to the
neuronal inductive stimuli, a greater proportion of DPSCs
stopped proliferation and acquired a phenotype resembling
mature neurons.
Stem cells can be used for tissue repair, treatment of
disease, and drug toxicity testing.38e41 The results of this
study support the use of DPSCs as promising candidates for
cell-based therapies for neuron disorders. DPSCs are easily
available from adult teeth such as wisdom teeth that are
sometimes extracted due to malpositioning. This procedure
of preparation of DPSCs is devoid of any relevant ethical
concerns. In addition, DPSCs can be easily handled in the
laboratory. They are expandable, cryopreservable, and
robust in culture. However, future studies should be carried
out to clarify whether DPSCs, apart from their neurotrophic
and neuroprotective effects, are also able to differentiate
into fully functional neurons.
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